NO954291L - Endothelin-reseptor-antagonister - Google Patents

Endothelin-reseptor-antagonister

Info

Publication number
NO954291L
NO954291L NO954291A NO954291A NO954291L NO 954291 L NO954291 L NO 954291L NO 954291 A NO954291 A NO 954291A NO 954291 A NO954291 A NO 954291A NO 954291 L NO954291 L NO 954291L
Authority
NO
Norway
Prior art keywords
receptor antagonists
endothelin receptor
endothelin
antagonists
receptor
Prior art date
Application number
NO954291A
Other languages
English (en)
Other versions
NO313754B1 (no
NO954291D0 (no
Inventor
Russell Donovan Cousins
John Duncan Elliott
Maria Amparo Lago
Jack Dale Leber
Catherine Elizabeth Peishoff
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO954291D0 publication Critical patent/NO954291D0/no
Publication of NO954291L publication Critical patent/NO954291L/no
Publication of NO313754B1 publication Critical patent/NO313754B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30Unsaturated compounds
    • C07C62/34Unsaturated compounds containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734Ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO19954291A 1993-04-27 1995-10-26 Endothelin-reseptor-antagonister, anvendelse og fremstilling derav samt farmasöytiske preparater NO313754B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6681893A 1993-04-27 1993-04-27
PCT/US1994/004603 WO1994025013A1 (en) 1993-04-27 1994-04-26 Endothelin receptor antagonists

Publications (3)

Publication Number Publication Date
NO954291D0 NO954291D0 (no) 1995-10-26
NO954291L true NO954291L (no) 1995-12-21
NO313754B1 NO313754B1 (no) 2002-11-25

Family

ID=22071916

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19954291A NO313754B1 (no) 1993-04-27 1995-10-26 Endothelin-reseptor-antagonister, anvendelse og fremstilling derav samt farmasöytiske preparater

Country Status (29)

Country Link
EP (1) EP0699069B9 (no)
JP (1) JP3346571B2 (no)
KR (1) KR100331667B1 (no)
CN (1) CN1129428C (no)
AP (1) AP573A (no)
AT (1) ATE213156T1 (no)
AU (1) AU682038B2 (no)
BR (1) BR9406572A (no)
CA (1) CA2160914A1 (no)
CZ (1) CZ291189B6 (no)
DE (1) DE69429861T2 (no)
DK (1) DK0699069T3 (no)
DZ (1) DZ1773A1 (no)
ES (1) ES2172535T3 (no)
FI (1) FI955103A (no)
HK (1) HK1012252A1 (no)
HU (2) HUT73763A (no)
IL (1) IL109443A0 (no)
MA (1) MA23172A1 (no)
NO (1) NO313754B1 (no)
NZ (1) NZ266314A (no)
PL (1) PL175392B1 (no)
PT (1) PT699069E (no)
RU (1) RU2130920C1 (no)
SG (1) SG49667A1 (no)
SI (1) SI9400195B (no)
SK (1) SK130595A3 (no)
TW (1) TW330204B (no)
WO (1) WO1994025013A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10510510A (ja) * 1994-06-09 1998-10-13 スミスクライン・ビーチャム・コーポレイション エンドセリン受容体拮抗物質
WO1995035107A1 (en) * 1994-06-20 1995-12-28 Smithkline Beecham Corporation Endothelin receptor antagonists
WO1996020193A1 (en) * 1994-12-23 1996-07-04 Smithkline Beecham Corporation Compounds and methods
US6080862A (en) * 1995-11-08 2000-06-27 Smithkline Beecham Corporation Stereoselective synthesis of endothelin receptor antagonists
WO1997017071A1 (en) * 1995-11-08 1997-05-15 Smithkline Beecham Corporation Stereoselective synthesis of endothelin receptor antagonists
US6162932A (en) * 1995-11-08 2000-12-19 Smithkline Beecham Corporation Stereoselective synthesis of endothelin receptor antagonists
ZA969363B (en) * 1995-11-08 1997-11-18 Smithkline Beecham Corp An improved process for preparing aromatic ring-fused cyclopentane derivatives.
US5977117A (en) * 1996-01-05 1999-11-02 Texas Biotechnology Corporation Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin
US5932553A (en) 1996-07-18 1999-08-03 The Regents Of The University Of California Illudin analogs useful as antitumor agents
US5723632A (en) 1996-08-08 1998-03-03 Mgi Pharma, Inc. Total synthesis of antitumor acylfulvenes
US6218427B1 (en) 1996-08-27 2001-04-17 Shionogi & Co., Ltd. Chromene-3-carboxylate derivatives
US5929106A (en) * 1997-10-27 1999-07-27 Smithkline Beecham Corporation Endothelin receptor antagonists
US7141603B2 (en) 1999-02-19 2006-11-28 The Regents Of The University California Antitumor agents
US6025328A (en) 1998-02-20 2000-02-15 The Regents Of The University Of California Antitumor agents
US6410554B1 (en) 1998-03-23 2002-06-25 Merck & Co., Inc. Combination therapy for the treatment of benign prostatic hyperplasia
AU747645B2 (en) * 1998-04-09 2002-05-16 Merck & Co., Inc. Phosphate-mediated cyclization
AR022228A1 (es) * 1999-01-12 2002-09-04 Abbott Gmbh & Co Kg Compuestos de triazol, composicion farmaceutica que los comprende y uso de los mismos para la preparar dicha composicion
US8168616B1 (en) 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
GB0327839D0 (en) 2003-12-01 2003-12-31 Novartis Ag Organic compounds
EP1729749A2 (en) 2004-03-17 2006-12-13 Novartis AG Use of renin inhibitors in therapy
US7423176B2 (en) 2004-04-13 2008-09-09 Cephalon, Inc. Bicyclic aromatic sulfinyl derivatives
RU2388748C2 (ru) 2004-12-21 2010-05-10 Ф. Хоффманн-Ля Рош Аг Производные тетралина и индана и их применения в качестве антагонистов 5-нт
EP1894582A1 (en) * 2005-06-24 2008-03-05 Tokyo Medical and Dental University Method for control of drug elution rate and composition for coating of drug-eluting stent
EP1909783B1 (en) 2005-08-03 2011-10-12 The Regents of the University of California Illudin analogs useful as anticancer agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ287406B6 (cs) * 1991-11-05 2000-11-15 Smithkline Beecham Corporation Indanové a indenové deriváty, způsob jejich výroby a farmaceutické prostředky s jejich obsahem

Also Published As

Publication number Publication date
SI9400195A (en) 1994-12-31
PT699069E (pt) 2002-07-31
TW330204B (en) 1998-04-21
DK0699069T3 (da) 2002-05-27
ES2172535T3 (es) 2002-10-01
DE69429861T2 (de) 2002-09-19
PL175392B1 (pl) 1998-12-31
CN1124923A (zh) 1996-06-19
AP573A (en) 1997-01-30
AU6775094A (en) 1994-11-21
HU9503067D0 (en) 1995-12-28
DZ1773A1 (fr) 2002-02-17
DE69429861D1 (de) 2002-03-21
IL109443A0 (en) 1994-07-31
AU682038B2 (en) 1997-09-18
EP0699069B9 (en) 2003-10-22
SK130595A3 (en) 1996-06-05
RU2130920C1 (ru) 1999-05-27
ATE213156T1 (de) 2002-02-15
NO313754B1 (no) 2002-11-25
CA2160914A1 (en) 1994-11-10
JP3346571B2 (ja) 2002-11-18
SG49667A1 (en) 1998-06-15
PL311272A1 (en) 1996-02-05
NZ266314A (en) 1998-10-28
KR100331667B1 (ko) 2002-11-08
SI9400195B (sl) 2003-10-31
AP9400636A0 (en) 1994-04-30
EP0699069B1 (en) 2002-02-13
EP0699069A1 (en) 1996-03-06
NO954291D0 (no) 1995-10-26
FI955103A0 (fi) 1995-10-26
JPH08510211A (ja) 1996-10-29
FI955103A (fi) 1995-10-26
HU9501931D0 (en) 1995-09-28
CZ291189B6 (cs) 2003-01-15
EP0699069A4 (no) 1996-04-03
CZ283595A3 (en) 1996-03-13
HUT73763A (en) 1996-09-30
CN1129428C (zh) 2003-12-03
WO1994025013A1 (en) 1994-11-10
BR9406572A (pt) 1996-01-30
MA23172A1 (fr) 1994-12-31
HK1012252A1 (en) 1999-07-30

Similar Documents

Publication Publication Date Title
FI961804A (fi) Endoteliinireseptoriantagonistit
DK0612244T3 (da) Endothelinreceptorantagonister
DE69327720D1 (de) Endothelin rezeptor antagonisten
FI960953A0 (fi) Endoteliinireseptoriantagonisteja
ATE213156T1 (de) Endothelin-rezeptor-antagonisten
NO972016D0 (no) Indolyl-Y-reseptorantagonister
NO943190L (no) Sulfonamid-endothelin-antagonister
ZA939516B (en) Endothelin receptor antagonists
FI960516A0 (fi) Substituoituja bifenyylisulfonamidiendoteliiniantagonisteja
KR960700722A (ko) 피브리노겐 수용체 길항제(Fibrinogen receptor antagonists)
NO20000542D0 (no) Endothelin-antagonister
BR9507220A (pt) Antagonistas de receptores de endotelina
ATE341324T1 (de) Endothelin rezeptor antagonisten
FI944905A0 (fi) Endoteliiniantagonistit II
BR9603432A (pt) Antagonistas de receptores de endotelina
EP0711157A4 (en) ENDOTHELIN RECEPTOR ANTAGONISTS
LV10425A (lv) Fibrinogena receptoru antagonisti